Stock Rating Report for MRK

Ticker: 

Stock Information

Ticker MRK
Company Name Merck and Co Inc
Current Price $38.37
Previous Close $38.37
Industry Drug Manufacturers - Major
Sector HEALTHCARE
Long Stop Loss Members Only
Short Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

StockProphet Ratings

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

Sector Risks

Sign up for MarketProphet today to see our 30, 60, and 90 day risk assessment for this stock.


Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for MRK. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Merck and Co Inc next week. Sign up today and start making money!

Demand Fundamentals

Demand Fundamental Value Score Rating
Qtr/Qtr Revenue Growth Members Only
Qtr/Qtr Earnings Growth Members Only
Year/Year Revenue Growth Members Only
Year/Year Earnings Growth Members Only
Multi-Year Revenue Growth Members Only
Multi-Year Earnings Growth Members Only
Relative PE Ranking Members Only
Return on Equity Members Only
Yield Members Only
Institutional Holding Members Only
Stock Price Members Only
Relative Fundamental Ranking Members Only
Total Score Members Only

Demand Technicals

Demand Technical Value Score Rating
Recommended Condition Members Only
Trading Zone Members Only
Average Trading Volume Members Only
Industry Bull/Bear Condition Members Only
Sector Bull/Bear Condition Members Only
Current Signal Start Date Members Only
Total Score Members Only

Company Profile

Merck and Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, diabetes and obesity, infectious diseases, neurosciences and ophthalmology, oncology, vaccines, and women's health and endocrine. This segment also offers human health vaccines, such as preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products. This segment offers antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fish. The Consumer Care segment develops, manufactures, and markets over-the-counter, foot care, and sun care products. Its over-the-counter product line includes non-drowsy antihistamines- treatment for occasional constipation- decongestant-free cold/flu medicine for people with high blood pressure- nasal decongestant spray- and treatment for frequent heartburn. This segment's foot care products comprise topical antifungal, and foot and sneaker odor/wetness products- and sun care products include sun care lotions, sprays and dry oils- and sunburn relief products. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, and managed health care providers, as well as food chain and mass merchandiser outlets in the United States and Canada. Merck and Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.


Latest News

Sat, 04 Feb 2012 17:12:04 GMT5 Blue Chips to Ride the Bull
Sat, 04 Feb 2012 14:24:29 GMTNew Star Analyst Rankings for Merck & Company, Inc. Common St
Sat, 04 Feb 2012 14:00:00 GMTMerck's Lower Tax Rate
Sat, 04 Feb 2012 13:47:16 GMTGroup lists top stock investments by members of Congress
Sat, 04 Feb 2012 04:42:04 GMTUltimate Market Recap: Consumer Banks Get a Boost, Social Media Companies Climbing
Sat, 04 Feb 2012 01:34:36 GMT2 Dow Stocks That Missed the Rally
Sat, 04 Feb 2012 00:26:06 GMTMicron, Depomed: After-Hours Trading (Update 1)
Fri, 03 Feb 2012 22:55:54 GMTAeropostale, Micron, Regal-Beloit, Zogenix: U.S. Equity Preview for Feb. 6
Fri, 03 Feb 2012 22:30:24 GMTDow Rallies to Pre-Recession Levels: McDonald's Leads Since May 2008
Fri, 03 Feb 2012 21:38:29 GMTCuring Diseases Makes For a Bad Business Model
Fri, 03 Feb 2012 21:16:21 GMTU.S. Companies Issuing Profit Outlooks for the Week of Feb. 3
Fri, 03 Feb 2012 21:14:31 GMTOn The Fly: Closing Wrap
Fri, 03 Feb 2012 19:53:58 GMTMerck Looks Like A Name To Own In Drugs
Fri, 03 Feb 2012 19:06:12 GMTGilead's Hep C Results Send Shares Sharply Higher
Fri, 03 Feb 2012 19:00:00 GMTMidday Market Report: Riding the Jobs Wave
Fri, 03 Feb 2012 18:49:43 GMTThreshold lands $25M upfront, possible $525M more, in cancer drug deal
Fri, 03 Feb 2012 18:19:55 GMTCould big pharma be a tonic for investors?
Fri, 03 Feb 2012 17:47:12 GMTThis Just In: Upgrades and Downgrades
Fri, 03 Feb 2012 17:07:22 GMTWait for This Company to Weather the Storm
Fri, 03 Feb 2012 16:40:00 GMTThree Stocks for the Dividend Craze
News provided by Yahoo! Finance